Nuclear FAK and Runx1 Cooperate to Regulate IGFBP3, Cell-Cycle Progression, and Tumor Growth

Marta Canel1,2, Adam Byron1, Andrew H Sims1

  • 1Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.

Cancer Research
|August 16, 2017
PubMed

Insights

Nuclear focal adhesion kinase (FAK) regulates gene expression in skin cancer. This study reveals FAK’s role in a novel molecular complex controlling tumor growth and cell-cycle progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Nuclear focal adhesion kinase (FAK) is implicated in cancer gene expression.
  • FAK influences cellular function and the tumor microenvironment.

Purpose of the Study:

  • Investigate the role of nuclear FAK in skin squamous cell carcinoma (SCC).
  • Elucidate the mechanism by which FAK regulates SCC cell-cycle progression and tumor growth.

Main Methods:

  • Utilized a murine model of skin SCC.
  • Identified and characterized a novel molecular complex involving FAK and Runx1 in SCC cell nuclei.
  • Analyzed FAK interactions with Runx1-regulatory proteins and epigenetic modifiers.

Main Results:

  • Nuclear FAK was found to regulate Runx1-dependent transcription of insulin-like growth factor binding protein 3 (IGFBP3).
  • This regulation impacts SCC cell-cycle progression and tumor growth in vivo.
  • A novel FAK-Runx1 molecular complex was identified, interacting with epigenetic modifiers like Sin3a.

Conclusions:

  • FAK acts as a scaffolding protein within nuclear molecular complexes that control gene transcription.
  • These findings offer new insights into FAK's function in regulating gene expression and tumor progression in SCC.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K